The mechanisms underlying the inhibitory effects of MALT1 in DSS-induced colitis have been ascribed to the inhibition on NF-κB and NLRP3 inflammasome activation in macrophages, thus implying that MALT1-NF-κB signaling regulates NLRP3 inflammasome activation. The gene discussed is NFKB1; the disease is colitis.